Survival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer

Cancer Research

Volumn 59, Issue 4, 1999, Pages 868-871

  Pharoah, Paul D P ^a,c   Easton, Douglas F ^a   Stockton, Diane L ^b   Gayther, Simon ^a   Ponder, Bruce A J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER GRADING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FAMILIAL CANCER; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; ONCOGENE; OVARY CANCER; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

BRCA2 PROTEIN; FEMALE; GENES, BRCA1; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; SURVIVAL RATE; TRANSCRIPTION FACTORS;

EID: 0033558282     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Marcus, J. N., Watson, P., Page, D. L., Narod, S. A., Lenoir, G. M., Tonin, P., Linder Stephenson, L., Salerno, G., Conway, T. A., and Lynch, H. T. Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer (Phila.), 77: 697-709, 1996.
2. Breast Cancer Linkage Consortium. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet, 349: 1505-1510, 1997.
3. Johannsson, O. T., Idvall, I., Anderson, C., Borg, A. B. R., Barkardottir, R. B., Egilsson, V., and Olsson, H. Tumour biological features of BRCA1-induced breast and ovarian cancer. Eur. J. Cancer, 33: 362-371, 1997.
4. Buller, R. E., Anderson, B., Connor, J. P., and Robinson, R. Familial ovarian cancer. Gynecol. Oncol., 51: 160-166, 1993.
5. Chang, J., Fryatt, I., Ponder, B., Fisher, C., and Gore, M. E. A matched control study of familial epithelial ovarian cancer: patient characteristics, response to chemotherapy and outcome. Ann. Oncol., 6: 80-82, 1995.
6. Rubin, S. C., Benjamin, I., Behhakhl, K., Takahashi, H., Morgan, M. A., LiVolsi, V. A., Berchuck, A., Muto, M. G., Garber, J. E., Weber, B. L., Lynch, H. T., and Boyd, J. Clinical and pathological features of ovarian cancer in women with germ-line mutations of. BRCA1. N. Engl. J. Med., 335: 1413-1416, 1996.
7. Johannsson, O. T., Ranstam, J., Borg, A., and Olsson, H. Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden. J. Clin. Oncol., 16: 398-404, 1998.
8. Brunet, J. S., Narod, S. A., Tonin, P., and Foulkes, W. D. BRCA1 mutations and survival in women with ovarian cancer. N. Engl. J. Med. 336: 1256, 1997.
9. Whitmore, S. E. BRCA1 mutations and survival in women with ovarian cancer. N. Engl. J. Med., 336: 1254-1255, 1997.
10. Burk, R. D. BRCA1 mutations and survival in women with ovarian cancer. N. Engl. J. Med., 336: 1255, 1997.
11. Johannsson, O., Ranstam, J., Borg, A., and Olsson, H. BRCA1 mutations and survival in women with ovarian cancer. N. Engl. J. Med., 336: 1255-1256, 1997.
12. Gayther, S. A., Harrington, P., Russell, P., Kharkevich, G., Garkavtseva, R. F., Ponder, B. A. J., and Group, U. F. O. C. S. Rapid detection of regionally clustered germ-line BRCA1 mutations by multiplex heteroduplex analysis. Am. J. Hum. Genet., 58: 451-456, 1996.
13. Gayther, S. A., Warren, W., Mazoyer, S., Russell, P. A., Harrington, P. A., Chiano, M., Seal, S., Hamoudi, R., van Rensburg, E. J., Dunning, A. M., Love, R., Evans, G., Easton, D., Clayton, D., Stratton, M. R., and Ponder, B. A. J. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat. Genet., 11: 428-433, 1995.
14. Narod, S., Tonin, P., Lynch, H., Watson, P., Feunteun, J., and Lenoir, G. Histology of BRCA1 associated ovarian cancer. Lancet, 343: 236, 1994.
15. Couch, F. J., and Hartmann, L. C. BRCA1 testing: advances and retreats. J. Am. Med. Assoc., 279: 955-957, 1998.